Starboard's Jeff Smith called on the company to assemble a special committee to investigate the matter, describing it as ...

Starboard Value LP (together with its affiliates, "Starboard" or "we"), a significant shareholder of Pfizer Inc. (NYSE: PFE) ("Pfizer" or the "Company"), today issued the below letter to Company's ...

Two former Pfizer top executives won’t participate in an activist investor’s effort to pressure the drugmaker to make changes ...

"We have decided not to be involved in the efforts of Starboard Value regarding Pfizer. We are fully supportive of Pfizer ...

Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...

Pfizer ( PFE 3.46%) was a stock on the move Wednesday, and not because of any news generated by the healthcare company.

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

Health insurance companies are expected to pull back slightly from Medicare Advantage investing in 2025. Instead, Modern Healthcare reports, they will focus on Dual-Eligible Special Needs Plans, or ...

Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

Pfizer Inc. CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...

Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer CEO Ian Read and former Pfizer CFO Frank D’Amelio: We have decided not to be involved n the efforts of Starboard Value ...